Sign In | Join Free | My
Hubei Jusheng Technology Co., Ltd.
Honesty is fundamental,Quality is life,lnnovation is power, and Service is soul!
Home > Raw Material Drug >

99% high Purity Raw Material Drug , BMS -790052 Daclatasvir Powder

99% high Purity Raw Material Drug , BMS -790052 Daclatasvir Powder

Brand Name : Jusheng Brand
Model Number : 1009119-64-5
Certification : ISO, 9001, USP
Place of Origin : China
MOQ : 10grams
Price : Discount is possible if your order is big enough
Payment Terms : T/T in advance, Money Gram, Western Union, Bank Transfer.
Supply Ability : 1000kg/month
Delivery Time : within 2 working days
Packaging Details : 10g, 20g, 50g , 100g, 500g. 1kg, 10kg
CAS : 1009119-64-5
Apparence : White Powder
Purity : 99%
Email :
Skype : live: linda_8965
Whatapp : +86 18871490254
Contact Now

99% high Purity Raw Material Drug , BMS -790052 Daclatasvir Powder

Quick detail

Name:Daclatasvir (BMS-790052)
CAS No.:1009119-64-5
Molecular Weight:738.875
Density:1.25 g/cm3
Boiling Point:1071.239 °C at 760 mmHg
Flash Point:601.664 °C
Appearance:White Powder

Daclatasvir Description

Daclatasvir (USAN, formerly BMS-790052, trade name Daklinza) is a drug for the treatment of hepatitis C (HCV).

Daclatasvir has been tested in combination regimens with pegylated interferon and ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.
It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.
There has been significant controversy over the price that Bristol-Myers Squibb has chosen to charge for the drug.

Daclatasvir Uses

Uses 1

Daclatasvir (brand name Daklinza) is a new medication used to treat hepatitis C.

Uses 2
Daclatasvir is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying in your body.
Uses 3Daclatasvir is used to treat genotype 3 chronic hepatitis C in adults without cirrhosis. This medicine is given together with another drug called sofosbuvir.
Uses 4
For others, daclatasvir can shorten treatment when added to pegylated interferon and ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.

Daclatasvir Work

  1. Daclatasvir is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is the first-ever approved HCV NS5A replication complex inhibitor, meaning it interferes with a protein the virus uses to reproduce.
  2. Daclatasvir should be combined with other medications, which may include other direct-acting antivirals that work differently – sofosbuvir (Sovaldi) or the HCV protease inhibitor asunaprevir (Sunvepra) – or pegylated interferon and ribavirin.

How effective is daclatasvir

Daclatasvir works better for some people than for others. Several factors predict how well someone will respond, including HCV genotype, extent of liver damage and previous treatment history. People with liver cirrhosis do not respond as well as those with mild or moderate liver fibrosis. Depending on which drugs daclatasvir is combined with, people who are new to treatment may have a better chance of being cured than those with little or no response to prior treatment.

However, factors that traditionally predict poor response to interferon-based therapy do not make as much difference with interferon-free treatment. These factors may be overcome by prolonging treatment or by adding another direct-acting antiviral or ribavirin.

Product Tags:

hair growth drugs


anti depression drugs

China Customized Inflatable Bumper Ball Game Bubble Adult Grass CE supplier

99% high Purity Raw Material Drug , BMS -790052 Daclatasvir Powder Images

Inquiry Cart 0
Send your message to this supplier
To: Hubei Jusheng Technology Co., Ltd.
Characters Remaining: (0/3000)